These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22499789)

  • 1. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.
    Kodama K; Horikoshi M; Toda K; Yamada S; Hara K; Irie J; Sirota M; Morgan AA; Chen R; Ohtsu H; Maeda S; Kadowaki T; Butte AJ
    Proc Natl Acad Sci U S A; 2012 May; 109(18):7049-54. PubMed ID: 22499789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice.
    Kodama K; Toda K; Morinaga S; Yamada S; Butte AJ
    Diabetes; 2015 Mar; 64(3):867-75. PubMed ID: 25294945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue.
    Liu LF; Kodama K; Wei K; Tolentino LL; Choi O; Engleman EG; Butte AJ; McLaughlin T
    Diabetologia; 2015 Jul; 58(7):1579-86. PubMed ID: 25952479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance.
    Kang HS; Liao G; DeGraff LM; Gerrish K; Bortner CD; Garantziotis S; Jetten AM
    PLoS One; 2013; 8(3):e58417. PubMed ID: 23505504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.
    Fan R; Toubal A; Goñi S; Drareni K; Huang Z; Alzaid F; Ballaire R; Ancel P; Liang N; Damdimopoulos A; Hainault I; Soprani A; Aron-Wisnewsky J; Foufelle F; Lawrence T; Gautier JF; Venteclef N; Treuter E
    Nat Med; 2016 Jul; 22(7):780-91. PubMed ID: 27270589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
    Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.
    Kintscher U; Hartge M; Hess K; Foryst-Ludwig A; Clemenz M; Wabitsch M; Fischer-Posovszky P; Barth TF; Dragun D; Skurk T; Hauner H; Blüher M; Unger T; Wolf AM; Knippschild U; Hombach V; Marx N
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1304-10. PubMed ID: 18420999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled hyaluronic acid nanoparticles: Implications as a nanomedicine for treatment of type 2 diabetes.
    Rho JG; Han HS; Han JH; Lee H; Nguyen VQ; Lee WH; Kwon S; Heo S; Yoon J; Shin HH; Lee EY; Kang H; Yang S; Lee EK; Park JH; Kim W
    J Control Release; 2018 Jun; 279():89-98. PubMed ID: 29649530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of regulatory T cells in obese omental adipose tissue in humans.
    Wu D; Han JM; Yu X; Lam AJ; Hoeppli RE; Pesenacker AM; Huang Q; Chen V; Speake C; Yorke E; Nguyen N; Sampath S; Harris D; Levings MK
    Eur J Immunol; 2019 Feb; 49(2):336-347. PubMed ID: 30566246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance.
    Wang J; Badeanlou L; Bielawski J; Ciaraldi TP; Samad F
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E756-68. PubMed ID: 24473437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.
    Xiong XQ; Geng Z; Zhou B; Zhang F; Han Y; Zhou YB; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Metabolism; 2018 Jun; 83():31-41. PubMed ID: 29374559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice.
    Baek Y; Lee MN; Wu D; Pae M
    J Nutr Biochem; 2019 Sep; 71():72-81. PubMed ID: 31302373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.
    Mamane Y; Chung Chan C; Lavallee G; Morin N; Xu LJ; Huang J; Gordon R; Thomas W; Lamb J; Schadt EE; Kennedy BP; Mancini JA
    Diabetes; 2009 Sep; 58(9):2006-17. PubMed ID: 19581423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 innate lymphoid cells are associated with type 2 diabetes.
    Liu F; Wang H; Feng W; Ye X; Sun X; Jiang C; Chu X; Zhang P; Jiang C; Wang Y; Zhu D; Bi Y
    Diabetes Metab; 2019 Sep; 45(4):341-346. PubMed ID: 30189343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.
    Nishimoto S; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Murata C; Kim-Kaneyama JR; Sato F; Bando M; Yagi S; Soeki T; Hayashi T; Imoto I; Sakaue H; Shimabukuro M; Sata M
    Sci Adv; 2016 Mar; 2(3):e1501332. PubMed ID: 27051864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin ligase Siah2 regulates obesity-induced adipose tissue inflammation.
    Kilroy G; Carter LE; Newman S; Burk DH; Manuel J; Möller A; Bowtell DD; Mynatt RL; Ghosh S; Floyd ZE
    Obesity (Silver Spring); 2015 Nov; 23(11):2223-32. PubMed ID: 26380945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.
    Nomiyama T; Perez-Tilve D; Ogawa D; Gizard F; Zhao Y; Heywood EB; Jones KL; Kawamori R; Cassis LA; Tschöp MH; Bruemmer D
    J Clin Invest; 2007 Oct; 117(10):2877-88. PubMed ID: 17823662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance causes inflammation in adipose tissue.
    Shimobayashi M; Albert V; Woelnerhanssen B; Frei IC; Weissenberger D; Meyer-Gerspach AC; Clement N; Moes S; Colombi M; Meier JA; Swierczynska MM; Jenö P; Beglinger C; Peterli R; Hall MN
    J Clin Invest; 2018 Apr; 128(4):1538-1550. PubMed ID: 29528335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ovarian function in association with a high-fat diet promotes insulin resistance and disturbs adipose tissue immune homeostasis.
    Pae M; Baek Y; Lee S; Wu D
    J Nutr Biochem; 2018 Jul; 57():93-102. PubMed ID: 29680663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.